Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of Cannabis sativa Using GC-FID
- 13 December 2017
- journal article
- research article
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 84 (04) , 250-259
Abstract
Cannabis (Cannabis sativa L.) is an annual herbaceous plant that belongs to the family Cannabaceae. Trans-Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are the two major phytocannabinoids accounting for over 40% of the cannabis plant extracts, depending on the variety. At the University of Mississippi, different strains of C. sativa, with different concentration ratios of CBD and Δ9-THC, have been tissue cultured via micropropagation and cultivated. A GC-FID method has been developed and validated for the qualitative and quantitative analysis of acid and neutral cannabinoids in C. sativa extracts. The method involves trimethyl silyl derivatization of the extracts. These cannabinoids include tetrahydrocannabivarian, CBD, cannabichromene, trans-Δ8-tetrahydrocannabinol, Δ9-THC, cannabigerol, cannabinol, cannabidiolic acid, cannabigerolic acid, and Δ9-tetrahydrocannabinolic acid-A. The concentration-response relationship of the method indicated a linear relationship between the concentration and peak area ratio with R2 > 0.999 for all 10 cannabinoids. The precision and accuracy of the method were found to be ≤ 15% and ± 5%, respectively. The limit of detection range was 0.11 – 0.19 µg/mL, and the limit of quantitation was 0.34 – 0.56 µg/mL for all 10 cannabinoids. The developed method is simple, sensitive, reproducible, and suitable for the detection and quantitation of acidic and neutral cannabinoids in different extracts of cannabis varieties. The method was applied to the analysis of these cannabinoids in different parts of the micropropagated cannabis plants (buds, leaves, roots, and stems).Keywords
This publication has 33 references indexed in Scilit:
- Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependenceDrug and Alcohol Dependence, 2012
- Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposesPhytochemistry, 2010
- Potency Trends of Δ9‐THC and Other Cannabinoids in Confiscated Cannabis Preparations from 1993 to 2008*Journal of Forensic Sciences, 2010
- A qualitative and quantitative HPTLC densitometry method for the analysis of cannabinoids in Cannabis sativa L.Phytochemical Analysis, 2009
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- Identification and Determination of Cannabinoids in both Commercially Available and Cannabis Oils Stored Long TermJournal of Health Science, 2005
- Cannabinoids in the Management of Severe Nausea and Vomiting from Cancer Chemotherapy. Some Additional ConsiderationsThe Journal of Clinical Pharmacology, 1981
- Biosynthesis of cannabinoid acidsPhytochemistry, 1975
- Constituents of Cannabis sativa L. VII: Use of Silyl Derivatives in Routine AnalysisJournal of Pharmaceutical Sciences, 1974
- Separation and identification of the constituents of hashish (cannabis indica linn.) by thin-layer chromatography and its application in forensic analysisMicrochimica Acta, 1974